News
Important Only
Planet Labs Stock Soars 34% After Earnings Report. Why Shares Are Headed to the Moon
Key PointsPlanet Labs reported break-even earnings per share on revenue of $81.3 million for its fiscal third quarter.The company updates its fiscal 2026 revenue guidance to a midpoint of $299 million, up from a previous outlook.Shares of Planet Labs are rising sharply after the earnings report.Plan...Tiger News
Thu, Dec 11
Barclays cuts Lennox's PT, cites HVAC market weakness
Barclays cuts price target on climate control product maker Lennox International LII.N to $680 from $700New PT represents an upside of 34.4% from stock's last close Brokerage notes LII's strong pricing power makes it attractive, but cyclical weakness in the residential HVAC market has weighe...Reuters
Thu, Dec 11
US STOCKS-Nasdaq slips to one-week low as Oracle reignites AI jitters
Indexes: Dow up 0.61%, S&P 500 off 0.45%, Nasdaq down 0.99%AI bubble fears impact crypto and tech stocksInvestors assess weekly jobless claims report Fed's rate cut brings optimism, but future rate path uncertainBy Johann M Cherian and Pranav Kashyap Dec 11 (Reuters) - Wall Street'...Reuters
Thu, Dec 11
Is This Ultra-High-Yield Dividend Stock a No-Brainer Heading Into 2026?
Key PointsCigarette maker Altria has increased its annual dividend for 56 consecutive years.It has used its pricing power to offset declining volume due to fewer adult smokers.With a forward P/E ratio of around 10.7, Altria is trading at a bargain by most standards.10 stocks we like better than Altr...The Motley Fool
Thu, Dec 11
Market Volatility and Opportunities
In this podcast, Motley Fool contributors Travis Hoium, Dan Caplinger, and Jon Quast discuss:Why the market is down.Bitcoin's drop.Where they see bargains.CEO Hall of Fame.To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're ready to invest, check ...The Motley Fool
Thu, Dec 11
Novo rises as Eli Lily drug's efficacy soothes concerns over CagriSema
Shares in Novo Nordisk NOVOb.CO rise more than 3% in late afternoon trade after Eli Lilly LLY.N study's results on the efficacy of its next generation obesity drug retatrutideJ.P,Morgan says the drug's efficacy seems similar; retatrutide achieved a 23.7% weight loss on an intention-to-treat ...Reuters
Thu, Dec 11
Titan Mining rises as ore feeding begins at Kilbourne graphite plant
Shares of Canadian miner Titan Mining TI.TO rise ~3% to C$3.18 in early tradingCo says ore feeding begins at its Kilbourne facility in New York state, advancing the project toward first graphite concentrate productionTI says output from facility will enable qualification runs and offtake discussion...Reuters
Thu, Dec 11
Barclays views Lilly, J&J as top acquirers in Abivax bid talk
Barclays says speculation of takeover interest for French biotech firm Abivax ABVX.PA "should not be surprising" given the compelling clinical profile of its inflammatory bowel disease (IBD) drug obefazimodBarclays sees Eli Lilly LLY.N and Johnson & Johnson JNJ.N as the "most logical...Reuters
Thu, Dec 11
Kosmos says Senegal has no plans to nationalise Yakaar-Teranga; shares down
Shares of oil and gas producer Kosmos Energy KOS.N down ~3% at $1.00 Company says Senegal's energy ministry has confirmed the country has no intention to nationalize the company's Yakaar-Teranga project Kosmos owns 90% stake in Yakaar-Teranga project, with the remaining held by state-owne...Reuters
Thu, Dec 11
Should You Buy Quantum Computing Stocks in 2026?
Key PointsThe sector is soaring because of a narrative around commercialization and disruption. The technology claims a lot of promises, but has failed to ever commercialize. These stocks are wildly expensive, burning cash, and heavily diluting shareholders. 10 stocks we like better than IonQ › Quan...The Motley Fool
Thu, Dec 11
Geron rises on plan to cut workforce
Shares of Geron Corp GERN.O rise 4.3% to $1.33Geron announces strategic restructuring plan to reduce workforce by a third, or about 260 roles Co expects to complete restructuring in Q1 2026Adds that it will incur restructuring charges consisting primarily of cash-based expenses in connection with pl...Reuters
Thu, Dec 11
SOFTS-New York cocoa hits five-week peak, coffee also up
LONDON, Dec 11 (Reuters) - New York cocoa futures climbed to a five-week peak on Thursday, buoyed primarily by speculative buying partly linked to its inclusion in the Bloomberg Commodity Index (BCOM) for 2026. COCOANew York cocoa CCc2 was up 1.7% to $6,336 a metric ton at 1450 GMT after hit...Reuters
Thu, Dec 11
LIVE MARKETS-Fed hangover: Stocks mixed, tech drags
S&P 500, Nasdaq lower; Dow gainsTech down most among S&P sectors; Materials lead gainersSTOXX 600 up 0.5%Dollar, crude, bitcoin down; gold turns greenUS 10-year Treasury yield falls to 4.10% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can sh...Reuters
Thu, Dec 11
Top 3 Vanguard Bond ETF Picks for 2026
Key PointsWith long end yields elevated, fixed income remains attractive across multiple segments.Rate cuts, corporate earnings, and stable credit markets are supportive to Vanguard’s VGHY and VCIT.With the dollar likely to weaken as U.S. rates fall, VWOB could extend its multi-year relative strengt...The Motley Fool
Thu, Dec 11
Enliven Therapeutics appoints Rick Fair as new CEO, shares down
Shares of drug developer Enliven Therapeutics ELVN.O down 1.7% at $19.82Enliven appoints Rick Fair as chief executive officer, effective December 11 Sam Kintz, co-founder and former CEO of Enliven, will assume a new role as Head of Pipeline, effective December 11Enliven plans to initiate a late-stag...Reuters
Thu, Dec 11
